TrialBMC medicine2023

Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC.

Yong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.